Rafael Garcia
Psychiatry · South Miami, FLNPI 1700224896
Payments from drug & device makers
Across 522 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$1K
- Sunovion Pharmaceuticals Inc.$960
- Otsuka America Pharmaceutical, Inc.$896
- Lundbeck LLC$882
- Johnson & Johnson$502
- plus $3K from 15 others
What the payments were for
- Food & beverage$9,016100%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $1,979 |
| Alkermes, Inc. | 60 | $1,080 |
| Sunovion Pharmaceuticals Inc. | 85 | $960 |
| Otsuka America Pharmaceutical, Inc. | 52 | $896 |
| Lundbeck LLC | 41 | $882 |
| Johnson & Johnson(2 entities) | 25 | $502 |
| Almatica Pharma LLC | 16 | $354 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $351 |
| Axsome Therapeutics, Inc. | 13 | $313 |
| Teva Pharmaceuticals USA, Inc. | 24 | $312 |
| Indivior Inc. | 16 | $307 |
| Neurocrine Biosciences, Inc. | 13 | $268 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $266 |
| Vanda Pharmaceuticals Inc. | 8 | $194 |
| E.r. Squibb & Sons, L.L.C. | 5 | $123 |
| Shire North American Group Inc | 8 | $112 |
| Acadia Pharmaceuticals Inc | 2 | $46 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Merck | 2 | $30 |
| Bausch Health US, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$9,048 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 80 | $265,028 |
| VraylarCariprazine Hcl | 178 | $261,173 |
| RexultiBrexpiprazole | 154 | $211,062 |
| AustedoDeutetrabenazine | 26 | $133,959 |
| Aripiprazole | 539 | $60,448 |
| LybalviOlanzapine/Samidorphan Malate | 38 | $58,784 |
| AristadaAripiprazole Lauroxil | 13 | $36,407 |
| Risperdal ConstaRisperidone Microspheres | 13 | $23,584 |
| TrintellixVortioxetine Hydrobromide | 47 | $22,720 |
| Lurasidone Hcl | 134 | $20,220 |
| CaplytaLumateperone Tosylate | 13 | $15,360 |
| Olanzapine | 223 | $14,229 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 98 | $11,331 |
| Quetiapine Fumarate | 856 | $11,145 |
| Chlorpromazine Hcl | 70 | $10,668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $502 | $288,61293 claims |
| AbbVieVraylar | $1,979 | $261,173178 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $896 | $211,062154 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $312 | $133,95926 claims |
| Alkermes, Inc.Lybalvi, Aristada | $1,080 | $95,19151 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $266 | $22,72047 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $351 | $15,36013 claims |
| MerckBelsomra | $30 | $6,24114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in South Miami
- Jose Guerra-ValenciaSouth Miami$1.7M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.